23andMe cuts 40% of its workforce and discontinues therapeutics division

NEW YORK (AP) -- 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs. Read More

23andMe cuts 40% of its workforce and discontinues therapeutics division

23andMe cuts 40% of its workforce and discontinues therapeutics division

23andMe cuts 40% of its workforce and discontinues therapeutics division

23andMe cuts 40% of its workforce and discontinues therapeutics division

23andMe cuts 40% of its workforce and discontinues therapeutics division